Diabetic cardiomyopathy and metabolic remodeling of the heart

Pavan K. Battiprolu, Camila Lopez-Crisosto, Zhao Wang, Andriy Nemchenko, Sergio Lavandero, Joseph A Hill

Research output: Contribution to journalReview articlepeer-review

68 Scopus citations


The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.

Original languageEnglish (US)
Pages (from-to)609-615
Number of pages7
JournalLife Sciences
Issue number11
StatePublished - 2013


  • Diabetic cardiomyopathy
  • FoxO
  • Heart
  • Insulin resistance
  • Metabolism
  • mTOR

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Diabetic cardiomyopathy and metabolic remodeling of the heart'. Together they form a unique fingerprint.

Cite this